Atle Fund Management AB Sells 12,055 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Atle Fund Management AB has reduced its stake in UnitedHealth Group by 46.8%, now holding 13,727 shares valued at approximately $4.28 million, and making it the fund's 22nd largest position.
• Several other hedge funds have increased their holdings in UnitedHealth Group, including GAMMA Investing LLC which raised its stake by 56,142.1%, owning over $4.34 billion worth of shares.
• UnitedHealth Group reported earnings of $4.08 per share for the last quarter, missing estimates by $0.37, with a market cap of $304.96 billion and an annualized dividend yield of 2.6%.

Atle Fund Management AB decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 46.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,727 shares of the healthcare conglomerate's stock after selling 12,055 shares during the period. UnitedHealth Group accounts for about 1.8% of Atle Fund Management AB's portfolio, making the stock its 22nd biggest position. Atle Fund Management AB's holdings in UnitedHealth Group were worth $4,282,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. Bayforest Capital Ltd lifted its holdings in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group during the first quarter worth about $42,000. Copia Wealth Management bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $42,000. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% in the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after acquiring an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Analysts Set New Price Targets

Several equities analysts recently weighed in on UNH shares. Barclays lifted their target price on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a research report on Friday, September 12th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $358.95.

UnitedHealth Group Stock Up 0.6%

UNH stock traded up $1.90 during mid-day trading on Friday, hitting $336.72. 13,528,738 shares of the company were exchanged, compared to its average volume of 13,684,542. The company has a market capitalization of $304.96 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The firm has a fifty day simple moving average of $295.67 and a 200 day simple moving average of $363.56. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.